Homepage
PR Newswire
20-02-2014, 04:09 PM
From Google Finance : Eckert & Ziegler Strahlen und Medizintechnik AG is a Germany-based Company engaged in the development and production of isotope technology components and medical technology equipment for medicine, science and manufacturing sectors. The Company operates in four main segments: Isotope Products, Radiation Therapy, Radiopharma, and Environmental Services. The Company manufactures products for diagnosis and treatment of cancer, remediation of contaminated sites and thickness measurement devices do the paper industry, among others. The Company has seven production sites and 10 distribution sites located worldwide and operates approximately 25 subsidiaries.
From Yahoo Finance : Key statistics are that it is a 131 Million Market Cap Company.
Most importantly, its EV/EBITDA is 5.1, screaming value buy at that EV/EBITDA.
Share price has fallen by 18% in last one month due to a result announcement that profit will fall by 15%.
The dividend is 0.6 Euro, with a 2.4% yield on cost.
I have done up a blog post on this, available here http://sgx-stocks-sti.blogspot.sg/2014/0...er-ag.html
Broadly, if you want to look at a stock for a 30% appreciation potential, this could be your ticket, if you buy at around 21 Euro.
From Yahoo Finance : Key statistics are that it is a 131 Million Market Cap Company.
Most importantly, its EV/EBITDA is 5.1, screaming value buy at that EV/EBITDA.
Share price has fallen by 18% in last one month due to a result announcement that profit will fall by 15%.
The dividend is 0.6 Euro, with a 2.4% yield on cost.
I have done up a blog post on this, available here http://sgx-stocks-sti.blogspot.sg/2014/0...er-ag.html
Broadly, if you want to look at a stock for a 30% appreciation potential, this could be your ticket, if you buy at around 21 Euro.
Disclaimer :-
I am not an investment professional.
I encourage you to do your own independent "due diligence" on any idea that I write about, because I could be and probably am wrong.
Nothing written here is an invitation to buy or sell any particular stock.
At most, I am handing out an educated guess as to what the markets may do.
The market will always find a new way to make a fool out of me (and maybe, even you!).
Even the best strategies of the past fail, sometimes spectacularly, when you least expect it.
I am not immune to that, so please understand that any past success of mine will probably be followed by failures
I am not an investment professional.
I encourage you to do your own independent "due diligence" on any idea that I write about, because I could be and probably am wrong.
Nothing written here is an invitation to buy or sell any particular stock.
At most, I am handing out an educated guess as to what the markets may do.
The market will always find a new way to make a fool out of me (and maybe, even you!).
Even the best strategies of the past fail, sometimes spectacularly, when you least expect it.
I am not immune to that, so please understand that any past success of mine will probably be followed by failures